Recruiting nowPhase 2Ages 18 Years and up
Hypofractionated Radiotherapy Followed by Surgical Resection in the Treatment of Soft Tissue Sarcomas
Sponsor: Vanderbilt-Ingram Cancer Center · NCT04506008 on ClinicalTrials.gov ↗
Conditions studied
Soft Tissue Sarcomas
What it tests
- Ultra-Hypo-fractionation Radiotherapyradiation
- Resectionprocedure
- Questionnaire Administrationother
- Moderately-Hypo-fractionation Radiotherapyradiation
Where it's running1 site
- Recruiting now
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee 37232
- Vanderbilt-Ingram Service for Timely Access(contact)800-811-8480[email protected]
- Eric Shinohara, MD(principal investigator)
See the official eligibility language
Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.
Inclusion Criteria: * Histologic diagnosis of a soft tissue sarcoma of extremity, pelvis, chest wall or trunk/abdominal wall (non-retroperitoneal location) * ECOG performance status 0-2 * Patient must be deemed able to comply with radiation treatment and surgery Exclusion Criteria: * History of prior radiation to the same area to be irradiated * Pregnancy * Active collagen vascular disease or patients genetically predisposed to increased radiation related side effects
Updated 2025-03-28 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.